Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction

被引:21
作者
Faxen, Jonas [1 ,2 ]
Jernberg, Tomas [3 ]
Hollenberg, Jacob [4 ]
Gadler, Fredrik [1 ,2 ]
Herlitz, Johan [5 ]
Szummer, Karolina [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Stockholm, Sweden
[3] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Stockholm, Sweden
[4] Karolinska Inst, Ctr Resuscitat Sci, Dept Med, Stockholm, Sweden
[5] Univ Boras, Fac Caring Sci Work Life & Social Welf, Prehosp Cent Re Prehosp Res, Boras, Sweden
关键词
cardiac arrest; epidemiology; myocardial infarction; predictors; sudden cardiac death; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SUDDEN-DEATH;
D O I
10.1016/j.jacc.2020.10.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The risk of sudden cardiac death (SCD) is high early after myocardial infarction (MI). Current knowledge and guidelines mainly rely on results from older clinical trials and registry studies. Left ventricular ejection fraction (LVEF) alone has not been proven a reliable predictor of SCD. OBJECTIVES This study sought to identify the incidence and additional predictors of SCD early after MI in a contemporary nationwide setting. METHODS The authors used data from SWEDEHEART, the Swedish Cardiopulmonary Resuscitation Registry, and the Swedish Pacemaker and Implantable Cardioverter-Defibrillator (ICD) Registry. Cases of MI, which had undergone coronary angiography and were discharged alive between 2009 to 2017 without a prior ICD, were followed up to 90 days. Cox regression models were used to assess associations between clinical parameters and out-of-hospital cardiac arrest (OHCA). RESULTS Among 121,379 cases, OHCA occurred in 349 (0.29%) and non-OHCA death in 2,194 (1.8%). A total of 6 variables (male sex, diabetes, estimated glomerular filtration rate <30 ml/min/1.73 m(2), Killip class >= II, new-onset atrial fibrillation/flutter, and impaired LVEF [reference << 50%] categorized as 40% to 49%, 30% to 39%, and <30%) were identified as independent predictors, were assigned points, and were grouped into 3 categories, where the incidence of OHCA ranged from 0.12% to 2.0% and non-OHCA death from 0.76% to 11.7%. Stratified by LVEF <40% alone, the incidence of OHCA was 0.20% and 0.76% and for non-OHCA death 1.1% and 4.9%. CONCLUSIONS In this nationwide study, the incidence of OHCA within 90 days after MI was <0.3%. A total of 5 clinical parameters in addition to LVEF predicted OHCA and non-OHCA death better than LVEF alone. (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:2926 / 2936
页数:11
相关论文
共 16 条
  • [1] Sudden Death After Myocardial Infarction
    Adabag, A. Selcuk
    Therneau, Terry M.
    Gersh, Bernard J.
    Weston, Susan A.
    Roger, Veronique L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (17): : 2022 - 2029
  • [2] Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054
  • [3] Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry
    Gadler, Fredrik
    Valzania, Cinzia
    Linde, Cecilia
    [J]. EUROPACE, 2015, 17 (01): : 69 - 77
  • [4] Survival after out-of-hospital cardiac arrest in Europe - Results of the EuReCa TWO study
    Graesner, Jan-Thorsten
    Wnent, Jan
    Herlitz, Johan
    Perkins, Gavin D.
    Lefering, Rolf
    Tjelmeland, Ingvild
    Koster, Rudolph W.
    Masterson, Siobhan
    Rossell-Ortiz, Fernando
    Maurer, Holger
    Boettiger, Bernd W.
    Moertl, Maximilian
    Mols, Pierre
    Alihodic, Hajriz
    Hadibegovic, Irzal
    Ioannides, Marios
    Truhlar, Anatolij
    Wissenberg, Mads
    Salo, Ari
    Escutnaire, Josephine
    Nikolaou, Nikolaos
    Nagy, Eniko
    Jonsson, Bergthor Steinn
    Wright, Peter
    Semeraro, Federico
    Clarens, Carlo
    Beesems, Steffie
    Cebula, Grzegorz
    Correia, Vitor H.
    Cimpoesu, Diana
    Raffay, Violetta
    Trenkler, Stefan
    Markota, Andrej
    Stroemsoee, Anneli
    Burkart, Roman
    Booth, Scott
    Bossaert, Leo
    [J]. RESUSCITATION, 2020, 148 : 218 - 226
  • [5] Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
    Hohnloser, SH
    Kuck, KH
    Dorian, P
    Roberts, RS
    Hampton, JR
    Hatala, R
    Fain, E
    Gent, M
    Connolly, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) : 2481 - 2488
  • [6] The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
    Jernberg, Tomas
    Attebring, Mona F.
    Hambraeus, Kristina
    Ivert, Torbjorn
    James, Stefan
    Jeppsson, Anders
    Lagerqvist, Bo
    Lindahl, Bertil
    Stenestrand, Ulf
    Wallentin, Lars
    [J]. HEART, 2010, 96 (20) : 1617 - 1621
  • [7] A New Equation to Estimate Glomerular Filtration Rate
    Levey, Andrew S.
    Stevens, Lesley A.
    Schmid, Christopher H.
    Zhang, Yaping
    Castro, Alejandro F., III
    Feldman, Harold I.
    Kusek, John W.
    Eggers, Paul
    Van Lente, Frederick
    Greene, Tom
    Coresh, Josef
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 604 - 612
  • [8] Wearable Cardioverter-Defibrillator after Myocardial Infarction
    Olgin, Jeffrey E.
    Pletcher, Mark J.
    Vittinghoff, Eric
    Wranicz, Jerzy
    Malik, Rajesh
    Morin, Daniel P.
    Zweibel, Steven
    Buxton, Alfred E.
    Elayi, Claude S.
    Chung, Eugene H.
    Rashba, Eric
    Borggrefe, Martin
    Hue, Trisha F.
    Maguire, Carol
    Lin, Feng
    Simon, Joel A.
    Hulley, Stephen
    Lee, Byron K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (13) : 1205 - 1215
  • [9] Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
    Piccini, Jonathan P.
    Zhang, Min
    Pieper, Karen
    Solomon, Scott D.
    Al-Khatib, Sana M.
    Van de Werf, Frans
    Pfeffer, Marc A.
    McMurray, John J. V.
    Califf, Robert M.
    Velazquez, Eric J.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (02) : 211 - 221
  • [10] 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
    Priori, Silvia G.
    Blomstrom-Lundqvist, Carina
    Mazzanti, Andrea
    Blom, Nico
    Borggrefe, Martin
    Camm, John
    Elliott, Perry Mark
    Fitzsimons, Donna
    Hatala, Robert
    Hindricks, Gerhard
    Kirchhof, Paulus
    Kjeldsen, Keld
    Kuck, Karl-Heinz
    Hernandez-Madrid, Antonio
    Nikolaou, Nikolaos
    Norekval, Tone M.
    Spaulding, Christian
    Van Veldhuisen, Dirk J.
    Kolh, Philippe
    Lip, Gregory Y. H.
    Agewall, Stefan
    Baron-Esquivias, Gonzalo
    Boriani, Giuseppe
    Budts, Werner
    Bueno, Hector
    Capodanno, Davide
    Carerj, Scipione
    Crespo-Leiro, Maria G.
    Czerny, Martin
    Deaton, Christi
    Dobrev, Dobromir
    Erol, Cetin
    Galderisi, Maurizio
    Gorenek, Bulent
    Kriebel, Thomas
    Lambiase, Pier
    Lancellotti, Patrizio
    Lane, Deirdre A.
    Lang, Irene
    Manolis, Athanasios J.
    Morais, Joao
    Moreno, Javier
    Piepoli, Massimo F.
    Rutten, Frans H.
    Sredniawa, Beata
    Zamorano, Jose L.
    Zannad, Faiez
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (41) : 2793 - +